Dauvilliers, Y., Plazzi, G., Mignot, E., Lammers, G. J., Villegas, R. D. R., Khatami, R., Taniguchi, M., Abraham, A., Hang, Y., Kadali, H., Lamberton, M., Sheikh, S., Stukalin, E., Neuwirth, R., Swick, T. J., Tanaka, S., Hehn, C. V., Rosenstiel, P. V., Wang, H., Cai, A., Naylor, M., Olsson, T. (2025). Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2405847